Before & After

  • Brenda, March 2010
    image description image description
  • April 2010
    image description image description
  • May 2010
    image description image description
  • May 2010
    image description image description

Contact Us Today!

XEOMIN Hyperhidrosis

The small “key” of the Botulinum toxin A molecule , the 150 kd short chain, is now approved in Canada for therapeutic use. There are no surrounding protective proteins around the molecule as with the first approved. BTX in Canada, BOTOX. We have worked with Xeomin in studies and with clinic patients for over 4 years.